| Range: | 2.0E-4-2.0E-4 | Vol Avg: | 0 | Last Div: | 0 | Changes: | -0.1 |
| Beta: | 1406.62 | Cap: | 0.00B | Currency: | USD | Exchange: | PNK |
| Sector: | Healthcare | IPO: | Tue Feb 09 2016 | Empoloyees: | 25 | ||
| CUSIP: | 03815L102 | CIK: | 0001607549 | ISIN: | US03815L1026 | Country: | US |
| CEO: | Mr. Christopher Michael Bridges | Website: | https://www.appliedbiocorp.com | ||||
APPB 0.00 Stock Price Applied Biosciences Corp.
Applied Biosciences Corp. focuses on the development and commercialization of synthetic cannabinoid therapeutics/biopharmaceuticals that target the endocannabinoid system to treat a range of diseases across various therapeutic areas. It also delivers consumer and OTC THC-free CBD products that promote overall health and wellbeing, as well as testing and analytics capabilities to its customers. The company was incorporated in 2014 and is based in Beverly Hills, California.
Stock Details
About The Monevue
The content provided on this site is for informational purposes only and does not constitute financial, investment, or professional advice. We are not registered investment advisors or financial planners, and we do not provide recommendations or advice on buying, selling, or holding any particular stocks or securities. Any investment decisions should be made based on your own research and consultation with a qualified financial professional. We are not responsible for any financial loss or damages incurred from reliance on the information provided on this site. Please invest responsibly and seek professional advice when needed.
• Powered by StackThrow